The Chief Executive Officers of These Four Companies Buy Shares, Plus Insider Selling at Sanmina Corp (SANM)

CEO of Allergan Buys Shares Amid Stock Price Weakness

Two high ranking executives at Allergan plc (NYSE:AGN) recently filed Form 4 filings with the SEC to disclose fresh purchases of shares. President and CEO Brenton L. Saunders snapped up 5,250 shares on Monday at prices varying from $188.43 to $189.81 per share. Following the recent purchase, the CEO currently holds an ownership stake of 106,564 shares. On November 11, Chief Financial Officer Maria Teresa Hilado bought 1,422 shares at prices that ranged from $208.00 to $213.31 per share. Ms. Hilado currently owns 13,379 shares.

In late July of 2015, Allergan plc (NYSE:AGN) agreed to sell its global generic pharmaceuticals business and certain other assets to Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA). Upon the closing of the deal in early August, Allergan received $33.3 billion in cash and 100.3 unregistered Teva ordinary shares with an aggregate value of around $5.0 billion at closing. In early October, the world’s biggest generic drugmaker acquired Allergan’s Anda Distribution business for an additional $500.0 million, a business that distributes generic, brand, specialty and OTC pharmaceutical products from more than 300 manufacturers to retail independent and chain pharmacies, nursing homes, mail order pharmacies, hospitals, clinics and physician offices across the United States. The shares of Allergan are 38% in the red this year. Dan Loeb’s Third Point LLC trimmed its stake in Allergan plc (NYSE:AGN) by 23% during the third quarter to 3.79 million shares.

CEO of Strong Performing Semiconductor-Equipment Maker Buys Shares

The man in charge of Kulicke and Soffa Industries Inc. (NASDAQ:KLIC) boosted his ownership stake through a large series of transactions this past week. President and CEO Fusen Ernie Chen increased his holding from 166,163 shares to 191,163 shares during the last two days of the previous week at prices varying from $14.52 to $15.33 per share.

Kulicke and Soffa Industries Inc. (NASDAQ:KLIC) designs, manufactures and sells capital equipment and expendable tools used to assemble semiconductor devices such as integrated circuits, high and low powered discrete devices, light-emitting diodes, and power modules. Although the shares of the semiconductor-equipment maker currently trade slightly under their 52-week high of $15.37, the company’s recently-appointed CEO bought shares without hesitation. The shares of Kulicke and Soffa Industries are 30% in the green so far this year, partly reflecting strong results for the quarter that ended October 1. While the company’s management anticipates the industry to return to a more normalized growth rate in the foreseeable future, Dr. Chen assured investors that the company’s process of driving efficiency through the manufacturing process and supply chain will enable the semiconductor-equipment maker to navigate the softer near-term outlook. Royce & Associates, founded by Chuck Royce, reported owning 1.68 million shares of Kulicke and Soffa Industries Inc. (NASDAQ:KLIC) in its 13F for the third quarter.

The final page of this article will discuss some insider buying observed at one company, and fresh insider selling at another company.